PATENT CLAIM ANALYSIS

Application Number: 16229563
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-10
Patent Classification: ["435", "377000"]

Abstract:
The present invention relates to methods for deriving novel stem cells from the mammalian early neural plate.

Claim (Index 13):
An isolated neural plate stem cell, or population of such cells maintained in culture for at least 12 passages in the presence of FGF4, wherein the NPSC maintain expression of the marker Brn-2 and do not express the markers Ngn2, MASH!, 50 Pax3, Pax6, En1, En2, and Krox20 on the NPSC,

Metadata:
- Claim Count in Document: 53.0
- Percentile: 98.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14395257', '12338749', '15446552', '14169286', '10928805']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5558371873035328
- 35 USC 102 Novelty (BERT): 0.666453959676925
- Combined Prediction Score: 0.566898864540872
- Mean Citation Score: 401.04012
- Max Citation Score: 685.1184
- Similarity Product: 614.8879913892746

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test